Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
35%
OVERLAP
BY WEIGHT
50
# OF OVERLAPPING
HOLDINGS
XLV
60
HOLDINGS
83%
ALSO IN FXH
FXH
77
HOLDINGS
66%
ALSO IN XLV
SECTOR DRIFT (XLV minus FXH)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XLV |
Weight in FXH |
Overlap | |
|---|---|---|---|---|
 |
ABBOTT LABORATORIES | 4.8% | 1.8% | 1.8% |
|
CIGNA CORPORATION | 1.8% | 2.2% | 1.8% |
|
PFIZER INC | 2.8% | 1.7% | 1.7% |
|
VERTEX PHARMACEUTICALS INC | 2.3% | 1.6% | 1.6% |
|
AMGEN INC | 3.1% | 1.6% | 1.6% |
XLV Overweight Relative to FXH
|
ELI LILLY & CO | 11.3% |
|
JOHNSON & JOHNSON | 7.1% |
|
ABBVIE INC | 5.4% |
|
UNITEDHEALTH GROUP INC | 5.0% |
|
MERCK & CO. INC. | 4.1% |
|
BOSTON SCIENTIFIC CORP | 3.2% |
|
ABBOTT LABORATORIES | 3.0% |
|
GILEAD SCIENCES INC | 2.8% |
|
INTUITIVE SURGICAL INC | 2.5% |
|
THERMO FISHER SCIENTIFIC INC | 2.4% |
XLV Underweight Relative to FXH
|
ELANCO ANIMAL HEALTH, INC. | -3.0% |
|
TENET HEALTHCARE CORP | -2.9% |
|
EXELIXIS INC | -2.6% |
|
DOXIMITY, INC. CLASS A | -2.4% |
|
ALNYLAM PHARMACEUTICALS INC | -2.2% |
|
INSULET CORP | -2.2% |
|
NATERA INC | -2.1% |
|
PENUMBRA, INC. | -2.1% |
|
UNITED THERAPEUTICS CORP | -2.0% |
|
PREMIER INC-CLASS A | -2.0% |